BERING Melanoma
|
Title in German |
Encorafenib plus Binimetinib bei Patienten mit lokal fortgeschrittenem, inoperablem oder metastasiertem BRAFV600-mutierten Melanom: eine multizentrische, nationale, prospektive, longitudinale, nicht-interventionelle Studie in der Schweiz |
|
Title in English |
Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAFV600-mutated melanoma: a multi-centric, national, prospective, longitudinal, non-interventional study in Switzerland |
|
Description |
|
|
Phase/Biobank/etc. |
|
|
Head Clinical Trial |
|
|
Study-Nurse |
|
|
Back-up |
|
|
Status |
open |
|
BASEC Nummer |
2020-00339 |
|
KOFAM |
|
|
WHO-Register-Nummer |
|
|
Insel-Nummer |
4741 |
CemiSkin
|
Title in German |
Eine nichtinterventionelle multizentrische, longitudinale 2-Kohorten Studie zur Wirksamkeit, Sicherheit und Quality of Life (QoL) bei Patienten mit fortgeschrittenem kutanen Plattenepithelkarzinom (adCSCC), die mit Cemiplimab (prospektive Kohorte) oder anderen Therapieansätzen behandelt werden |
|
Title in English |
Two cohort registry study for patients with advanced CSCC treated with Cemiplimab or other approaches |
|
Description |
This is a non-interventional multicenter study in Germany, Austria and Switzerland. The study includes two cohorts of adult patients with advCSCC who receive either treatment with Cemiplimab (prospective cohort) or other therapeutic approaches (retrospective cohort). Enrollment will take place at approx. 70 study sites. The selection of participating sites will attempt to capture a representative sample of advCSCC treating clinic and office based physicians to get data from a real world setting outside of clinical trials. |
|
Phase/Biobank etc. |
|
|
Head Clinical Trial |
|
|
Study-Nurse |
|
|
Back-up |
|
|
Status |
|
|
BASEC Nummer |
2022-00155 |
|
KOFAM |
|
|
WHO-Register-Nummer |
|
|
Insel-Nummer |
Correlation of histological and peripheral eosinohilic count with survival of malignant melanoma (thicker than 1mm): A prospective study
|
Titel in German |
Korrelation der histologischen und peripheren Eosinophilenzahl mit dem Überleben eines malignen Melanoms (dicker als 1 mm): Eine prospektive Studie |
|
Title in English |
Correlation of histological and peripheral eosinohilic count with survival of malignant melanoma (thicker than 1mm): A prospective study |
|
Description |
Forschungsstudie |
|
Phase |
|
|
Head Clinical Study |
|
|
Study-Nurse |
|
|
Back-up |
|
|
Status |
open |
|
BASEC Nummer |
2021-01340 |
|
KOFAM |
|
|
WHO-Register-Nummer |
|
|
Insel-Nummer |
4956 |
Neo-DREAM
|
Title in German |
Eine Studie, um die Wirksamkeit von Daromun (L19IL2 + L19TNF) vor der Krebsoperation gefolgt von Standardtherapie (Operation mit nachfolgender unterstützender Therapie) im Vergleich zur Standardtherapie in Patienten mit schwarzem Hautkrebs im Stadium IIIB/C zu untersuchen |
|
Title in English |
An Open-Label, Randomized, Controlled Multi-Center Study of The Efficacy of Daromun (L19IL2 + L19TNF) Neoadjuvant Intratumoral Treatment Followed by Surgery and Adjuvant Therapy Versus Surgery and Adjuvant Therapy in Clinical Stage IIIB/C Melanoma Patients |
|
Description |
The purpose of this clinical trial is to test whether treatment with Daromun before surgical removal of all tumors (called neoadjuvant therapy) followed by supportive therapy after surgery (adjuvant therapy) statistically significantly increases the time to disease recurrence compared to standard therapy. |
|
Phase/Biobank/etc. |
IV |
|
Studienleiter |
|
|
Study-Nurse |
|
|
Back-up |
|
|
Status |
|
|
BASEC Nummer |
2022-00440 |
|
KOFAM |
|
|
WHO-Register-Nummer |
NCT03567889 |
|
Insel-Nummer |